Ishizuka, Yasunobu
Omori, Takeshi
Shinno, Naoki
Yamamoto, Masaaki
Hara, Hisashi
Otsuka, Tomoyuki
Nishio, Minako
Nishida, Naohiro
Fujisawa, Fumie
Sugimoto, Naotoshi
Yagi, Toshinari
Goto, Masahiro
Nishikawa, Hiroki
Kudo, Toshihiro
Article History
Received: 12 June 2023
Accepted: 7 November 2023
First Online: 27 November 2023
Competing interests
: Dr. Naotoshi Sugimoto received honoraria from Chugai Pharm, Daiichi Sankyo, Eli Lilly, Behlinger Ingerheim, Ono, MSD and Pfizer, outside the submitted work. Dr. Toshinari Yagi received honoraria from Becton Dickinson and Eisai, outside the submitted work. Toshihiro Kudo received speaker bureaus from Taiho, Daiichi Sankyo, Bristol-Myers Squibb, MSD, Merck Biopharma, Chugai, Ono and Eli Lilly, and participated on a data safety monitoring board or advisory board of Zymeworks Inc, outside the submitted work. All remaining authors have declared no conflicts of interest.